Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can stop Mounjaro at any time — there is no physical dependency, and the medicine carries no licensed withdrawal protocol. That said, stopping has real consequences worth understanding before you make the call. Mounjaro is a prescription-only medicine, so any planned change to your treatment should involve your prescriber. Here is what the clinical picture actually looks like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works by activating GIP and GLP-1 receptors in a way that slows gastric emptying and damps appetite signals. Stop injecting, and those signals return. For most people this means hunger climbs back relatively quickly (often within days of the last dose wearing off) and body weight tends to follow within weeks to months. This is not a failure of willpower. It reflects the underlying biology that made treatment useful in the first place.
Clinical trial data back this up. The SURMOUNT-1 study published in the New England Journal of Medicine found that a substantial proportion of weight lost during active treatment was regained after stopping, a pattern also observed in semaglutide trials. That context matters when you are weighing up a break.
None of this means stopping is the wrong decision. It means it is a decision best made with your eyes open and, ideally, with a plan for what comes next. If you are wondering about the detail of what a short gap actually involves, the one-week pause question has its own practical answer.
For weight management alone, there is no medical requirement to taper down through lower doses before stopping. Unlike some other medicines, Mounjaro does not have a licensed tapering protocol for discontinuation. If you are asking whether you can stop Mounjaro at any point in your treatment, the short answer is that you can stop after any pen without stepping down first.
The picture is slightly different if you are using tirzepatide partly for type 2 diabetes management alongside weight loss. Blood-sugar control may change when you stop, and your prescriber or diabetes team should know your plan in advance. The NHS tirzepatide patient information page is a reliable first reference, and your Patient Information Leaflet covers individual clinical considerations in full.
One practical point many people overlook: if you stop and then want to restart, your prescriber will typically need to reassess your dose. Restarting at the dose you were on (rather than the 2.5 mg starter) is not automatic, and returning to a higher dose without that review increases gastrointestinal side-effect risk. The stop-and-restart question covers that process in more detail.
There are legitimate reasons to stop Mounjaro, and nobody should feel they need to stay on treatment indefinitely if it is not working for them. Common reasons prescribers discuss with patients include: side effects that are not settling with time, a planned pregnancy (Mounjaro is not recommended during pregnancy or while trying to conceive, a wash-out period applies, so raise this early), a surgical procedure coming up where your anaesthetist needs to be told you are on a GLP-1 medicine, or simply a personal decision after reaching a sustainable weight.
If the motivation is cost, it is worth reading how weight-loss treatment is priced in the UK private market before deciding, a break followed by a restart is not always cheaper in the long run if weight regain means returning to a starting dose.
Stopping because you feel it is not doing anything is worth a frank conversation first. The medication's appetite effects can be subtle at lower doses, and many people find the difference only becomes clear once they have stopped. Our FAQs address some of the most common mid-treatment doubts.
At nume, a prescriber personally reviews every repeat before it goes out, so you already have a direct line to that conversation. If you are thinking of stopping, tell them why. A prescriber can flag anything clinically important (diabetes management changes, the contraception wash-out timing if you are planning a pregnancy, or the safest way to handle an upcoming surgery), and can note it in your records so a future restart is smoother.
If you are partway through a pen, you do not have to finish it before stopping, and if you are unsure whether it is safe to simply stop Mounjaro without any additional steps, that question has a dedicated answer worth reading before you decide. Unused medication should be disposed of safely, a sharps container is the right way to dispose of used needles and pens. Side effects after your last dose generally resolve as the medicine clears your system, though this can take a couple of weeks given tirzepatide's half-life.
Honestly, most people asking this question are not planning to quit permanently, they are anxious about what stopping means, or weighing a temporary break. That is completely understandable. Some people also ask about practical aspects of their current routine, such as whether Mounjaro needs to be taken at the same time each week, or whether supplements such as l-carnitine can be taken alongside tirzepatide. To explore your options with a prescriber who can look at your actual situation, speak to our clinical team, no assumption either way about what you should do.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.